An overview of currently available circulatory assist devices (CADs) is presented with discussion of each system’s optimal use and limitations. Successful application of CAD technology for bridge to transplant or pending recovery of the natural heart requires understanding issues involving team readiness, patient selection, device limitations, patient management, and complications. Currently, many of these devices are in clinical trials with the Food and Drug Administration (FDA). The FDA and the National Institutes of Health play major roles in the ongoing development of this technology. In the near future the learning curve continues as totally implantable systems are used. The ultimate goal is to maintain patients with heart failure on implantable devices with a good quality of life at a reasonable cost
Cirdiac Assist Devices| August 01 1991
Current Perspectives on the Use of Circulatory Assist Devices
Richard G. Smith, MSEE, CCE;
From the Artificial Heart Program, University Medical Center, Tucson, Arizona.
Reprint requests to Richard G. Smith, MSEF., CCE, Artificial Heart Program, University Medical Center, Tucson, AZ 8572–4.
Search for other works by this author on:
AACN Adv Crit Care (1991) 2 (3): 488–499.
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
- Search Site
Richard G. Smith, Marilyn Cleavinger; Current Perspectives on the Use of Circulatory Assist Devices. AACN Adv Crit Care 1 August 1991; 2 (3): 488–499. doi: https://doi.org/10.4037/15597768-1991-3014
Download citation file: